The Clorox Company (NYSE:CLX) Shares Sold by Entropy Technologies LP

Entropy Technologies LP trimmed its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 35.6% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 6,825 shares of the company's stock after selling 3,767 shares during the quarter. Entropy Technologies LP's holdings in Clorox were worth $1,112,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of CLX. Mizuho Markets Americas LLC grew its stake in shares of Clorox by 93.7% in the first quarter. Mizuho Markets Americas LLC now owns 72,053 shares of the company's stock worth $11,032,000 after acquiring an additional 34,864 shares in the last quarter. CANADA LIFE ASSURANCE Co increased its holdings in Clorox by 15.2% during the 1st quarter. CANADA LIFE ASSURANCE Co now owns 141,622 shares of the company's stock worth $21,705,000 after purchasing an additional 18,687 shares during the period. Advisors Asset Management Inc. raised its position in Clorox by 257.5% in the 1st quarter. Advisors Asset Management Inc. now owns 11,228 shares of the company's stock valued at $1,719,000 after purchasing an additional 8,087 shares in the last quarter. Catalyst Capital Advisors LLC purchased a new position in shares of Clorox in the 3rd quarter valued at about $54,000. Finally, Raymond James & Associates grew its position in shares of Clorox by 32.8% during the second quarter. Raymond James & Associates now owns 267,632 shares of the company's stock worth $36,524,000 after buying an additional 66,149 shares in the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling

In related news, EVP Angela C. Hilt sold 1,733 shares of the company's stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company's stock, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.57% of the company's stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on CLX shares. Barclays raised their price objective on shares of Clorox from $137.00 to $139.00 and gave the company an "underweight" rating in a report on Friday, November 1st. BNP Paribas upgraded Clorox to a "strong sell" rating in a research note on Friday, September 6th. DA Davidson increased their price target on shares of Clorox from $153.00 to $171.00 and gave the company a "neutral" rating in a research note on Monday, November 4th. Evercore ISI dropped their target price on shares of Clorox from $140.00 to $139.00 and set an "underperform" rating on the stock in a research report on Monday, October 14th. Finally, JPMorgan Chase & Co. raised their price objective on Clorox from $148.00 to $174.00 and gave the stock a "neutral" rating in a report on Friday, October 11th. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of "Hold" and an average price target of $155.00.

Clorox Stock Performance

CLX traded up $0.38 during trading on Thursday, hitting $165.74. The stock had a trading volume of 774,950 shares, compared to its average volume of 1,241,837. The Clorox Company has a twelve month low of $127.60 and a twelve month high of $169.09. The firm has a market capitalization of $20.52 billion, a P/E ratio of 57.62, a PEG ratio of 3.04 and a beta of 0.41. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The company's 50-day moving average price is $162.38 and its 200 day moving average price is $147.21.

Clorox (NYSE:CLX - Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, topping analysts' consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. During the same quarter in the prior year, the company posted $0.49 earnings per share. Clorox's quarterly revenue was up 27.0% on a year-over-year basis. On average, equities research analysts forecast that The Clorox Company will post 6.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were paid a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.94%. The ex-dividend date was Wednesday, October 23rd. Clorox's dividend payout ratio (DPR) is presently 170.04%.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.